CoreWeave officer McVeety proposes 5-share sale

The sale is tied to tax withholding on the vesting and settlement of equity awards.

Rhea-AI Filing Summary

CoreWeave, Inc. officer Kristen McVeety reports a proposed sale of 5 common shares, with an aggregate market value of $438.43 and an approximate sale date of September 30, 2026. The shares are to be sold automatically under a mandatory, non-discretionary sell-to-cover arrangement adopted by CoreWeave, Inc. to satisfy tax withholding obligations incurred upon vesting and settlement of equity awards.

Key Figures

Common shares proposed for sale: 5 shares Aggregate market value of proposed sale: $438.43 Common shares sold: 55,945 shares +3 more

6 metrics

Common shares proposed for sale 5 shares Approximate sale date: September 30, 2026

Aggregate market value of proposed sale $438.43 Proposed sale of 5 common shares

Common shares sold 55,945 shares Reported sale on September 8, 2026

Aggregate value of common shares sold $5,232,882.71 Reported sale on September 8, 2026

Common shares sold 41,555 shares Reported sale on September 8, 2026

Aggregate value of common shares sold $3,925,883.69 Reported sale on September 8, 2026

Key Terms

sell-to-cover arrangement, Rule 144, Restricted Stock

3 terms

sell-to-cover arrangement financial

"mandatory, non-discretionary, sell-to-cover arrangement"

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Nature of securities acquired: Restricted Stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CRWV shares does Kristen McVeety plan to sell?

Kristen McVeety, an officer of CoreWeave, Inc., reports a proposed sale of 5 common shares with an aggregate market value of $438.43, with an approximate sale date of September 30, 2026.

What CRWV stock sales did Kristen McVeety report for September 8, 2026?

On September 8, 2026, Kristen McVeety reported two common-stock sales: 55,945 shares for $5,232,882.71 and 41,555 shares for $3,925,883.69.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/30/2026 - 05:02 PM Accepted by SEC EDGAR 09/30/2026 - 05:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002058048
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COREWEAVE, INC.
SEC File Number	001-42563
Address of Issuer	290 W. MT. PLEASANT AVENUE, SUITE 4100 LIVINGSTON NEW JERSEY 07039
Phone	(973) 270-9737
Name of Person for Whose Account the Securities are To Be Sold	KRISTEN MCVEETY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5	438.43	458871690	09/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2026	Restricted Stock	Issuer			5	09/30/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
McVeety Kristen J 290 W Mt. Pleasant Ave Suite 4100 Livingston NJ 07039	Common	09/08/2026	55945	5232882.71
McVeety Kristen J 290 W Mt. Pleasant Ave Suite 4100 Livingston NJ 07039	Common	09/08/2026	41555	3925883.69
McVeety Kristen J 290 W Mt. Pleasant Ave Suite 4100 Livingston NJ 07039	Common	09/01/2026	94307	7718622.43
McVeety Kristen J 290 W Mt. Pleasant Ave Suite 4100 Livingston NJ 07039	Common	09/01/2026	55506	4505100.09
McVeety Kristen J 290 W Mt. Pleasant Ave Suite 4100 Livingston NJ 07039	Common	09/01/2026	6187	510406.46
McVeety Kristen J 290 W Mt. Pleasant Ave Suite 4100 Livingston NJ 07039	Common	08/26/2026	1144	100880.44
McVeety Kristen J 290 W Mt. Pleasant Ave Suite 4100 Livingston NJ 07039	Common	08/26/2026	724	63269.49
McVeety Kristen J 290 W Mt. Pleasant Ave Suite 4100 Livingston NJ 07039	Common	08/26/2026	232	20704.58
KRISTEN MCVEETY 290 W Mt. Pleasant Ave Suite 4100 Livingston NJ 07039	Common	08/20/2026	3980	365698.32
KRISTEN MCVEETY 290 W Mt. Pleasant Ave Suite 4100 Livingston NJ 07039	Common	07/06/2026	22	1889.62

144: Remarks and Signature

Remarks	The Shares covered by this Form 144 are being sold automatically pursuant to a mandatory, non-discretionary, sell-to-cover arrangement adopted by the Issuer for the purpose of satisfying tax withholding obligations incurred upon the vesting and settlement of equity awards
Date of Notice	09/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kristen J McVeety
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)